Efficacy News and Research

RSS
Positive results from LifeCycle Pharma's LCP-Tacro comparative trial in de novo liver transplant patients

Positive results from LifeCycle Pharma's LCP-Tacro comparative trial in de novo liver transplant patients

Positive topline results from RDEA594 Phase 2b study in patients with gout, allopurinol

Positive topline results from RDEA594 Phase 2b study in patients with gout, allopurinol

CeNeRx commences TriRima Phase II trial for treatment resistant depression

CeNeRx commences TriRima Phase II trial for treatment resistant depression

Altheus Therapeutics announces completion of Zoenasa phase I trial for ulcerative colitis

Altheus Therapeutics announces completion of Zoenasa phase I trial for ulcerative colitis

Choosing between EGFR therapeutic options in metastatic colorectal cancer

Choosing between EGFR therapeutic options in metastatic colorectal cancer

Problems reported with Implanon contraceptive implant

Problems reported with Implanon contraceptive implant

Study shows clinical benefits of iniparib in combination with standard chemotherapy for triple-negative breast cancer

Study shows clinical benefits of iniparib in combination with standard chemotherapy for triple-negative breast cancer

Symphogen closes €100 million stock to a group of investors

Symphogen closes €100 million stock to a group of investors

Findings of AM095 in various in vitro, in vivo models of fibrotic disease published in JPET

Findings of AM095 in various in vitro, in vivo models of fibrotic disease published in JPET

Studies show XIFAXAN 550 mg tablets demonstrate significant relief of global IBS symptoms

Studies show XIFAXAN 550 mg tablets demonstrate significant relief of global IBS symptoms

Sanofi-aventis announces publication of positive BSI-201 phase II results for breast cancer

Sanofi-aventis announces publication of positive BSI-201 phase II results for breast cancer

Scientists identify prognostic biomarker to treat patients with HCV

Scientists identify prognostic biomarker to treat patients with HCV

FDA awards supplemental approval to support efficacy of ACTEMRA in treating RA

FDA awards supplemental approval to support efficacy of ACTEMRA in treating RA

Positive topline results from ZGN-433 Phase 1b study in obesity patients

Positive topline results from ZGN-433 Phase 1b study in obesity patients

Nicotine replacement therapies to quit smoking

Nicotine replacement therapies to quit smoking

Insite Vision announces completion of patient enrollment in ISV-303 Phase 1/2 trial for post surgical ocular pain, inflammation

Insite Vision announces completion of patient enrollment in ISV-303 Phase 1/2 trial for post surgical ocular pain, inflammation

Researchers regenerate complete shoulder joint surfaces using patient's own cells

Researchers regenerate complete shoulder joint surfaces using patient's own cells

Avaxia Biologics generates compelling pre-clinical data in animal models of IBD

Avaxia Biologics generates compelling pre-clinical data in animal models of IBD

Omeros receives exclusive license for new series of antifibrinolytic agents

Omeros receives exclusive license for new series of antifibrinolytic agents

FDA grants additional marketing exclusivity to INOMAX for pediatric BPD treatment

FDA grants additional marketing exclusivity to INOMAX for pediatric BPD treatment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.